By Professor Dedee Frances Murrell

Journal articles

Teng J; Paller AS; Bruckner AL; Murrell DF; Mellerio JE; Bodemer C; Martinez AE; Lugo-Somolinos A; Sprecher E; Laimer M; Wally V; Chan YM; Lin SY; Spellman M; Bauer JW, 2023, 'Diacerein 1% Ointment for the Treatment of Epidermolysis Bullosa Simplex: A Randomized, Controlled Trial', Journal of Drugs in Dermatology, 22, pp. 599 - 604, http://dx.doi.org/10.36849/JDD.7108

Murrell DF; Teng JMC; Guenthner S; Marathe K; Kempers S; Eads K; Castelo-Soccio L; Mendelsohn AM; Raiz J; Bunick CG, 2023, 'Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis', Clinical and Experimental Dermatology, 48, pp. 623 - 630, http://dx.doi.org/10.1093/ced/llad033

Cowan TL; Ho G; Daniel BS; Murrell DF, 2023, 'Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemic', JAAD International, 11, pp. 33 - 34, http://dx.doi.org/10.1016/j.jdin.2022.03.016

Tada Y; Takeoka S; Spelman L; Murrell D; Wu J; Zoob P; Bosman K; Chu C-Y; Chung W-H, 2023, 'ISID0459 - Demographics, comorbidities and disease severity before dupilumab treatment initiation in Asian patients with atopic dermatitis', , http://dx.doi.org/10.26226/m.641999e770c3630019098d8e

Wang M; Murrell D; Wilson A; Daniel B; Daniel Lara Rivero A; Martin L; Johannes J, 2023, 'ISID0396 - A novel investigator global assessment score for the evaluation of keratosis pilaris', , http://dx.doi.org/10.26226/m.641999e460d56100127c27b2

Lee H; Cowan TL; Daniel BS; Murrell DF, 2023, 'A review of JAK and IL-23 inhibitors to treat vitiligo', Australasian Journal of Dermatology, 64, pp. 204 - 212, http://dx.doi.org/10.1111/ajd.14001

Johal JS; Cowan TL; Murrell DF, 2023, 'Evaluating the nature and prevalence of glucocorticoid-induced type 2 diabetes mellitus in patients with autoimmune bullous diseases', Clinical and Experimental Dermatology, 48, pp. 448 - 452, http://dx.doi.org/10.1093/ced/llac137

Johal J; Cowan T; BILGIC A; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Mundin C; Ramirez Quizon M; Kakuta R; Takahashi H; Wilson A; Zeng F; Murrell D; H. Stone J, 2023, 'ISID0390 - Examining the risk factors for worsened glucocorticoid morbidity in a prospective, multicentre, international study of patients with autoimmune blistering diseases.', , http://dx.doi.org/10.26226/m.641999e288811f001400fb3d

Wilson A; Tariq Khan M; Murrell DF, 2023, 'Median canaliform nail dystrophy in a 2-year-old boy: Case report and review of the literature', Pediatric Dermatology, 40, pp. 511 - 518, http://dx.doi.org/10.1111/pde.15181

Aung T; Noakes R; Murrell DF; Daniel BS; Kelati A, 2023, 'Primary cutaneous amyloidosis: A review of the available studies and gaps in data', Australasian Journal of Dermatology, 64, pp. e121 - e124, http://dx.doi.org/10.1111/ajd.14012

Williams TG; Hackett LM; Lam PH; Stitz DJ; Al-Housni H; Murrell DF; Murrell GAC, 2023, 'Fibrillar matrix, Echogenicity, Contour, Thickness, and Suture (FECTS) vs. Global: A comparison of 2 scales developed to assess ultrasound images post rotator cuff repair', Journal of Shoulder and Elbow Surgery, 32, pp. 713 - 728, http://dx.doi.org/10.1016/j.jse.2022.10.035

Tully JM; Murase JE; Grant-Kels JM; Murrell DF, 2023, 'Gender Equity in Medicine and Dermatology in the United States: The Long Road Traveled and the Journey ahead', Dermatologic Clinics, 41, pp. 265 - 278, http://dx.doi.org/10.1016/j.det.2022.08.007

Boucher D; Wilson A; Murrell DF, 2023, 'Pemphigus scoring systems and their validation studies – A review of the literature', Dermatologica Sinica, 41, pp. 67 - 77, http://dx.doi.org/10.4103/ds.DS-D-22-00150

Xie D; Bilgic A; Abu Alrub N; Dicle Ö; Murrell DF, 2023, 'Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study', JAAD International, 10, pp. 6 - 13, http://dx.doi.org/10.1016/j.jdin.2022.08.025

Wilson A; Cowan TL; Rivero ADL; Murrell DF, 2023, 'The dangers of social media: patients with atopic dermatitis ceasing their basic treatment', Clinical and Experimental Dermatology, 48, pp. 142 - 143, http://dx.doi.org/10.1093/ced/llac056

COWAN T; ABU ALRUB N; WİLSON A; MAKHİJA M; MURRELL D, 2023, 'Tildrakizumab for the treatment of exfoliative cheilitis', Mucosa, 6, pp. 19 - 21, http://dx.doi.org/10.33204/mucosa.1209480

Murrell DF; Joly P; Werth VP; Laws E; Mannent LP; Beazley B; Dubost-Brama A; Shabbir A, 2023, '307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT', British Journal of Dermatology, 188, http://dx.doi.org/10.1093/bjd/ljac140.007

Hundt JE; Sadik CD; van Beek N; Busch H; Caux F; Goebeler M; Hammers CM; Hartmann K; Hashimoto T; Ibrahim S; Kasperkiewicz M; Murrell DF; Recke A; Rose C; Schumacher N; Shimanovich I; Sitaru C; Terheyden P; Thaçi D; Ludwig RJ; Schmidt E, 2023, 'A life for autoimmune blistering diseases: in memoriam Detlef Zillikens', Frontiers in Immunology, 14, http://dx.doi.org/10.3389/fimmu.2023.1291590

Koszegi B; Stone C; Murrell DF, 2023, 'Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1149742

Patsatsi A; Daneshpazhooh M; Tavakolpour S; Mahmoudi H; Murrell DF, 2023, 'Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II', Frontiers in Medicine, 10, http://dx.doi.org/10.3389/fmed.2023.1268285

Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF, 2023, 'Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study', British Journal of Dermatology, 188, pp. 12 - 21, http://dx.doi.org/10.1093/bjd/ljac001

Rodriguez R; Sivesind TE; Murrell D; Dellavalle RP, 2023, 'From the Cochrane Library: Interventions for Pemphigus Vulgaris and Pemphigus Foliaceus', JMIR Dermatology, 6, http://dx.doi.org/10.2196/46812

Huang C; Bullpitt P; Nabarrro M; Murrell DF, 2023, 'Practice Dilemma: Expanding Melanonychia in the Paediatric Setting', Skin Appendage Disorders, 9, pp. 58 - 60, http://dx.doi.org/10.1159/000526102

Johal J; Cowan T; Bilgic A; Bozca B; Enli S; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Mundin C; Quizon M; Kakuta R; Takahashi H; Wilson A; Zeng F; Murrell D, 2023, '390 Examining the risk factors for worsened glucocorticoid morbidity in a prospective, multicentre, international study of patients with autoimmune blistering diseases', Journal of Investigative Dermatology, 143, pp. S67 - S67, http://dx.doi.org/10.1016/j.jid.2023.03.396

Wang MA; Wilson A; Daniel B; Rivero ADL; Martin L; Kern JS; Murrell D, 2023, '396 A novel investigator global assessment score for the evaluation of keratosis pilaris', Journal of Investigative Dermatology, 143, pp. S68 - S68, http://dx.doi.org/10.1016/j.jid.2023.03.402

Tada Y; Takeoka S; Spelman L; Murrell D; Chu C; Chung W; Wu J; Zoob P; Bosman K, 2023, '459 Demographics, comorbidities and disease severity before dupilumab treatment initiation in Asian patients with atopic dermatitis', Journal of Investigative Dermatology, 143, pp. S79 - S79, http://dx.doi.org/10.1016/j.jid.2023.03.465

Joly P; Patel HV; Cella RR; Kephart L; Murrell D, 2023, '639 Design of marigold-bp: A phase 2/3 study of nipocalimab in adults with moderate to severe bullous pemphigoid', Journal of Investigative Dermatology, 143, pp. S109 - S109, http://dx.doi.org/10.1016/j.jid.2023.03.646

Schmidt E; Diaz LA; Amagai M; Murrell DF, 2023, 'Detlef Zillikens, 1958-2022', Journal of Investigative Dermatology, 143, pp. 7 - 8, http://dx.doi.org/10.1016/j.jid.2022.11.001

Keller Rosenthal N; Boucher D; Murrell DF, 2022, 'The efficacy of adding oral sodium cromoglycate to stable treatment for controlling bullous pemphigoid-related pruritus: A retrospective study', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1051804

So JY; Fulchand S; Wong CY; Li S; Nazaroff J; Gorell ES; de Souza MP; Murrell DF; Teng JM; Chiou AS; Tang JY, 2022, 'A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex', Orphanet Journal of Rare Diseases, 17, http://dx.doi.org/10.1186/s13023-022-02433-3

Paller AS; Pope E; Rudin D; Malyala A; Ramsdell D; Johnson R; Landy H; Murrell DF, 2022, 'A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa', Orphanet Journal of Rare Diseases, 17, http://dx.doi.org/10.1186/s13023-022-02461-z

Vermeer MCSC; Al-Shinnag M; Silljé HHW; Gaytan AE; Murrell DF; McGaughran J; Melbourne W; Cowan T; van den Akker PC; van Spaendonck-Zwarts KY; van der Meer P; Bolling MC, 2022, 'A translation re-initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation', British Journal of Dermatology, 187, pp. 1045 - 1048, http://dx.doi.org/10.1111/bjd.21832

Mazaherpour E; Kianfar N; Dasdar S; Sedaghat M; Seyrafi H; Balighi K; Saberi F; Nili A; Farimani Z; Azar PM; Mahmoodi H; Murrell DF; Daneshpazhooh M, 2022, 'Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab-treated and rituximab-naïve patients', Dermatologic Therapy, 35, http://dx.doi.org/10.1111/dth.15902

Ho G; Gibson M; Kazemikhoo N; Murrell DF, 2022, 'Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies', JAAD International, 9, pp. 105 - 107, http://dx.doi.org/10.1016/j.jdin.2022.07.008

Lee BWH; Taylor SF; Gal A; Murrell DF; Coroneo MT, 2022, 'Sebaceous cell carcinoma presenting as ocular Marjolin ulcer following immunosuppression for a chemical burn', Canadian Journal of Ophthalmology, 57, pp. e206 - e208, http://dx.doi.org/10.1016/j.jcjo.2022.02.023

Zeng FAP; Wilson A; Sheriff T; Murrell DF, 2022, 'Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review', JAAD International, 9, pp. 33 - 43, http://dx.doi.org/10.1016/j.jdin.2022.07.005

Teng JMC; Bunick CG; Guenthner S; Murrell DF; Marathe K; Kempers S; Eads K; Mendelsohn AM; Raiz J; Tavakkol A; Castelo-Soccio L, 2022, 'The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis', Journal of the American Academy of Dermatology, 87, pp. 1455 - 1458, http://dx.doi.org/10.1016/j.jaad.2022.07.028

Zeng FAP; Murrell DF, 2022, 'Bullous pemphigoid—What do we know about the most recent therapies?', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.1057096

Bilgic A; Murrell DF, 2022, 'Designing the Future of Dermatology and Venereology', EMJ Dermatology, pp. 18 - 19, http://dx.doi.org/10.33590/emjdermatol/10176803

Karakioulaki M; Murrell DF; Kyriakou A; Patsatsi A, 2022, 'Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications', International Journal of Women's Dermatology, 8, http://dx.doi.org/10.1097/JW9.0000000000000053

Murrell DF; Patsatsi A; Stavropoulos P; Baum S; Zeeli T; Kern JS; Sinclair R; Neale A; Arora P; Sugerman PB; Shi G; Werth VP; Caux F; Joly P; Patsatsi A; Sinclair R; Neale A; Arora P; Shi G; Werth VP; Caux F; Joly P; Stavropolous P; Baum S, 2022, 'Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris', Journal of the European Academy of Dermatology and Venereology, 36, pp. 852 - 855, http://dx.doi.org/10.1111/jdv.18318

Borradori L; Van Beek N; Feliciani C; Tedbirt B; Antiga E; Bergman R; Böckle BC; Caproni M; Caux F; Chandran NS; Cianchini G; Daneshpazhooh M; De D; Didona D; Di Zenzo GM; Dmochowski M; Drenovska K; Ehrchen J; Goebeler M; Groves R; Günther C; Horvath B; Hertl M; Hofmann S; Ioannides D; Itzlinger-Monshi B; Jedličková J; Kowalewski C; Kridin K; Lim YL; Marinovic B; Marzano AV; Mascaro JM; Meijer JM; Murrell D; Patsatsi K; Pincelli C; Prost C; Rappersberger K; Sárdy M; Setterfield J; Shahid M; Sprecher E; Tasanen K; Uzun S; Vassileva S; Vestergaard K; Vorobyev A; Vujic I; Wang G; Wozniak K; Yayli S; Zambruno G; Zillikens D; Schmidt E; Joly P, 2022, 'Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)', Journal of the European Academy of Dermatology and Venereology, 36, pp. 1689 - 1704, http://dx.doi.org/10.1111/jdv.18220

Hall R; Culton D; Liu Z; Ujiie H; Schmidt E; Murrell D; Stoykov I; Verheesen P; Borradori L; Joly P, 2022, 'ESDR070 - Treating Bullous Pemphigoid by Inhibiting FcRn: A Phase 2/3 Trial with Efgartigimod', , http://dx.doi.org/10.26226/m.62fa009023ef91001a663bab

Wu D; Daniel BS; Lai AJX; Wong N; Lim DKA; Murrell DF; Lim BXH; Mehta JS; Lim CHL, 2022, 'Dupilumab-associated ocular manifestations: A review of clinical presentations and management', Survey of Ophthalmology, 67, pp. 1419 - 1442, http://dx.doi.org/10.1016/j.survophthal.2022.02.002

Ohri S; Sun M; Wilson BN; Murrell DF; Murase JE, 2022, 'Evaluating skin colour representation in the Indian Journal of Dermatology, Venereology and Leprology', Indian Journal of Dermatology, Venereology and Leprology, 88, pp. 678 - 679, http://dx.doi.org/10.25259/IJDVL_947_2021

Mahmoudi H; Patsatsi A; Murrell DF; Tavakolpour S; Daneshpazhooh M, 2022, 'Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.987534

Cowan TL; Murrell DF; Lara Rivero A, 2022, 'Allergic contact dermatitis to miconazole for nipple candidiasis', Contact dermatitis, 87, pp. 201 - 202, http://dx.doi.org/10.1111/cod.14125

Cowan TL; Wilson A; Murrell DF, 2022, 'Mental health, insomnia and suicidal ideation during treatment with apremilast', Australasian Journal of Dermatology, 63, pp. 403 - 404, http://dx.doi.org/10.1111/ajd.13864

Wi D; Wilson A; Satgé F; Murrell DF, 2022, 'Psoriasis and osteoporosis: a literature review', Clinical and Experimental Dermatology, 47, pp. 1438 - 1445, http://dx.doi.org/10.1111/ced.15174

Foley P; Spelman L; Murrell DF; Mate E; Tronnberg R; Lowe PM, 2022, 'Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study', Australasian Journal of Dermatology, 63, pp. 312 - 320, http://dx.doi.org/10.1111/ajd.13893

Back to profile page